Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122793
Filing Date
2024-11-07
Accepted
2024-11-07 07:17:26
Documents
77
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q upb-20240930.htm   iXBRL 10-Q 2653194
2 EX-31.1 upb-ex31_1.htm EX-31.1 16545
3 EX-31.2 upb-ex31_2.htm EX-31.2 16362
4 EX-32.1 upb-ex32_1.htm EX-32.1 14250
  Complete submission text file 0000950170-24-122793.txt   9259413

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT upb-20240930.xsd EX-101.SCH 1112861
79 EXTRACTED XBRL INSTANCE DOCUMENT upb-20240930_htm.xml XML 1533221
Mailing Address 890 WINTER STREET, SUITE 200 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 200 WALTHAM MA 02451 781-208-2466
Upstream Bio, Inc. (Filer) CIK: 0002022626 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42366 | Film No.: 241433157
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)